![Snehal Naik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Snehal Naik
Directeur Technique/Scientifique/R&D chez
VENTYX BIOSCIENCES, INC.
Profil
Snehal Naik currently holds the position of Chief Development Officer at Equillium, Inc. starting in 2026.
Dr. Naik is also Senior Vice President-Clinical Development at Ventyx Biosciences, Inc. since 2024, with employment at Ventyx Biosciences beginning in 2021.
The education history includes an undergraduate degree from the University of Kentucky and a doctorate from Temple University School of Medicine.
Postes actifs de Snehal Naik
| Sociétés | Poste | Début |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 01/02/2024 |
| EQUILLIUM, INC. | Corporate Officer/Principal | 01/05/2026 |
Formation de Snehal Naik
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Kentucky
 University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University School of Medicine
 Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Equillium, Inc.
 Equillium, Inc. BiotechnologyHealth Technology Engages in the development of products for severe immune-inflammatory disorders | Health Technology |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
